Animal Husbandry and Feed Science ›› 2022, Vol. 43 ›› Issue (1): 115-118.doi: 10.12160/j.issn.1672-5190.2022.01.019

• Veterinary Pharmaceutical Science • Previous Articles     Next Articles

Research Progress of African Swine Fever Vaccine

LI Yun-na1, WANG Guan2, JIA Hao1, DAI Xiao-guang1, SU Sheng-jie1, WANG Xu-hong1   

  1. 1. Inner Mongolia Center for Animal Disease Prevention and Control,Hohhot 010010,China;
    2. Inner Mongolia Center for Quality and Safety of Agriculture and Livestock Products,Hohhot 010010,China
  • Received:2021-12-10 Online:2022-01-30 Published:2022-02-10

Abstract: African swine fever (ASF) is an acute and hemorrhagic infectious disease caused by the African swine fever virus (ASFV) in farmed pigs and wild boars. Pigs infected with a highly virulent ASFV strain have a near 100% mortality rate, resulting in massive economic losses for the pig industry. ASFV spreads quickly and effectively in pigs and persists in the environment, posing challenges for prevention and control of ASF. The development of ASF vaccine has been a priority for researchers. There hasn′t been a successful vaccine on the market yet. In order to give a reference for successful research and development of ASF vaccine, this paper reviewed the current research status of ASF inactivated vaccine, live attenuated vaccine, subunit vaccine, DNA vaccine, and live viral vector vaccine.

Key words: African swine fever, vaccine, research and development progress

CLC Number: